Jonathan is a venture capital investor specialising in the biotechnology sector, helping to form and fund start-up companies developing novel therapeutics, and has sat on the boards of several company developing innovative new medicines and diagnostics.

Jonathan started his career in academic research, with a PhD in rare disease genetics from UCL, postdoctoral research at Cancer Research UK, and then moved into the biotech industry. He has a first class degree in Biology from Oxford and an MBA with distinction from Imperial.

Passionate about autism research, Jonathan believes it is an underserved area that has huge potential to benefit the millions of people with autism and their families.